CNSX:BOSSThe Yield Growth Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding The Yield Growth Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.14 +0.01 (+7.69 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range$0.13Now: $0.14▼$0.1450-Day Range$0.14MA: $0.16▼$0.2152-Week Range N/AVolume418,735 shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAnalyst RatingsAdvanced ChartCompetitorsHeadlines The Yield Growth Corp., through its subsidiaries, develops, markets, and sells of wellness products. The company offers cosmetic and therapeutic products made of cannabis sativa hemp root oil and essential oils; and an anti-aging serum and a lip balm under the Urban Juve brand. It also provides massage and body oils, face mists, moisturizers, deodorants, and topical creams for acute and chronic pain. The company was formerly known as Cannapay Financial Inc. and changed its name to The Yield Growth Corp. in April 2018. The Yield Growth Corp. was incorporated in 2014 and is based in Vancouver, Canada.Read More Beat the Market (BTM) Rank™ 3.5 Analyst's Opinion Consensus RatingThe Yield Growth has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $0.45, The Yield Growth has a potential upside of 221.4% from its current price of $0.14.Amount of Analyst CoverageThe Yield Growth has received no research coverage in the past 90 days. Previous Next 2.3 Community Rank Outperform VotesThe Yield Growth has received 15 “outperform” votes. (Add your “outperform” vote.)Underperform VotesThe Yield Growth has received 17 “underperform” votes. (Add your “underperform” vote.)Community SentimentThe Yield Growth has received 53.13% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about The Yield Growth and other stocks. Vote “Outperform” if you believe BOSS will outperform the S&P 500 over the long term. Vote “Underperform” if you believe BOSS will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldThe Yield Growth does not currently pay a dividend.Dividend GrowthThe Yield Growth does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, The Yield Growth insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.16 out of 5 stars Industry, Sector and Symbol Stock Exchange CNSX Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCNSX:BOSS Previous Symbol CUSIPN/A CIKN/A Webyieldgrowth.com Phone833-515-2677Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable TSXV:BOSS Rates by TradingView Receive BOSS News and Ratings via Email Sign-up to receive the latest news and ratings for BOSS and its competitors with MarketBeat's FREE daily newsletter. The Yield Growth (CNSX:BOSS) Frequently Asked Questions Do Wall Street analysts recommend investors buy shares of The Yield Growth? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for The Yield Growth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for The Yield Growth. What price target have analysts set for BOSS? 1 equities research analysts have issued 1 year target prices for The Yield Growth's shares. Their forecasts range from $0.45 to $0.45. On average, they expect The Yield Growth's stock price to reach $0.45 in the next year. This suggests a possible upside of 221.4% from the stock's current price. View analysts' price targets for The Yield Growth. Has The Yield Growth been receiving favorable news coverage? Media coverage about BOSS stock has trended positive on Friday, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. The Yield Growth earned a media sentiment score of 3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news aboutThe Yield Growth. Who are some of The Yield Growth's key competitors? Some companies that are related to The Yield Growth include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF). View all competitors. What other stocks do shareholders of The Yield Growth own? Based on aggregate information from My MarketBeat watchlists, some companies that other The Yield Growth investors own include EPR Properties (EPR), Akerna (KERN), AIM ImmunoTech (AIM), Agile Therapeutics (AGRX), AgraFlora Organics International (AGRA), Alamos Gold (AGI), AgraFlora Organics International (AGFAF), Advaxis (ADXS), Adaptimmune Therapeutics (ADAP) and Acreage (ACRGF). Who are The Yield Growth's key executives? The Yield Growth's management team includes the following people: Ms. Penny Olga Green, CEO, Pres & Director (Age 47)Mr. Yucai Huang CPA, CGA, CFO & Exec. OfficerMs. Amy Frankel, Exec. Officer, VP of Licensing, Gen. Counsel & Corp. Sec. What is The Yield Growth's stock symbol? The Yield Growth trades on the CNSX under the ticker symbol "BOSS." How do I buy shares of The Yield Growth? Shares of BOSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is The Yield Growth's stock price today? One share of BOSS stock can currently be purchased for approximately $0.14. What is The Yield Growth's official website? The official website for The Yield Growth is yieldgrowth.com. How can I contact The Yield Growth? The company can be reached via phone at 833-515-2677. This page was last updated on 6/5/2020 by MarketBeat.com Staff
